GlassScriptPhysician profile
Taylor R Bixby
NPI 1689217077
$2,271.66
in general payments reported to CMS, 2019-2025
22 companies · $419 in 2025
The $419 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,446 · 2024: $407 · 2025: $419.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817 · Education: $9.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.68 |
| Education | $9.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $411.75 | 2021 | |
| Medtronic, INC. | $337.47 | 2024-2025 | Intellis Adaptivestim, Inceptiv |
| Otsuka America Pharmaceutical, INC. | $235.37 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $196.56 | 2021 | |
| Biotronik Nro, INC. | $146.38 | 2025 | Prospera |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $116.46 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $111.21 | 2021 | |
| Sunovion Pharmaceuticals INC. | $110.64 | 2021 | |
| Saluda Medical Americas, INC. | $106.81 | 2024 | Evoke |
| Axsome Therapeutics, INC. | $93.03 | 2025 | Symbravo |
| Janssen Pharmaceuticals, INC | $65.63 | 2021 | |
| Vertos Medical, INC. | $55.02 | 2024 | Mild Device Kit |
| Boston Scientific Corporation | $52.28 | 2025 | General - Pain Management, Intracept |
| Curonix LLC | $34.69 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Alkermes, INC. | $32.27 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $30.77 | 2021 | |
| Bausch Health US, LLC | $30.55 | 2021 | |
| Lundbeck LLC | $26.33 | 2021 | |
| Merck Sharp & Dohme LLC | $23.87 | 2021 | |
| Tris Pharma INC | $19.19 | 2021 | |
| Chiesi USA, INC. | $18.97 | 2021 | |
| Avanir Pharmaceuticals, INC. | $16.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Bixby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.